Apexigen, Inc. (APGN) Stock Analysis
DELISTED 2023
What happened to Apexigen, Inc. (APGN) stock?
Apexigen, Inc. (APGN) no longer trades on public markets. It was delisted in August 2023. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- August 2023
- Last recorded price (historical):
- $0.3851 (last quote on record before the August 2023 delisting; historical, not a current quote)
Market cap $9.57M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Apexigen, Inc. (APGN). Apexigen, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing antibody therapeutics for oncology. Their pipeline includes APX005M, APX601, and APX801, targeting various cancers.
Last analyzed: Mar 17, 2026Apexigen, Inc. (APGN) Healthcare & Pipeline Overview
More about this archive record
Can I still buy APGN shares?
No. APGN stopped trading on public markets in August 2023, so the shares are not available through a broker. Anything you see quoted for APGN elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before APGN stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Apexigen, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.